SCHEMBL3685533

SCHEMBL3685533

CCCCC(CC)COC(=O)CS.CCCCC(CC)COC(=O)CS.CCCCCCCC[Sn]CCCCCCCC

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.57
TSHR P16473 3/20 0.57
TDP1 Q9NUW8 2/20 0.57
ATM Q13315 1/20 0.57
RECQL P46063 1/20 0.49
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
ALDH1A1 P00352 6/20 0.45
CA2 P00918 2/20 0.45
LMNA P02545 4/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPK1 P28482 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.36
DUSP3 P51452 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8128069 1.00 CYP3A4 (0.57) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL3677109 1.00 CYP3A4 (0.57) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL28449038 0.94 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL1684087 0.94 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL17889800 0.88 CYP3A4 (0.68) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL16447750 0.88 CYP3A4 (0.68) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL27210 0.88 CYP3A4 (0.72) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL10946403 0.87 CYP3A4 (0.66) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL962909 0.87 CYP3A4 (0.70) CYP3A4TSHRTDP1ATMRECQL
Hydrogen Sulfide SCHEMBL7193596 0.87 CYP3A4 (0.70) CYP3A4TSHRTDP1ATMRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4729526-A2 BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS Galata Chemicals, LLC (US) 2026-04-22 EP claimed
US-20260092210-A1 BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS GALATA CHEMICALS LLC (US) 2026-04-02 US claimed
EP-0538673-B1 Clear, vapour-sterilisable, non-zytotoxic, essentially compact polyurethane casting compounds, process for their preparation and their use, especially for medical-technical articles BASF AG (DE) 1998-01-07 EP claimed
US-5306798-A Transparent, autoclavable, non-cytotoxic, essentially compact polyurethane embedding compositions, the preparation thereof and the use thereof, especially for articles used in medicine BASF AKTIENGESELLSCHAFT (DE) 1994-04-26 US claimed
EP-4729526-A2 BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS Galata Chemicals, LLC (US) 2026-04-22 EP disclosed
US-20260092210-A1 BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS GALATA CHEMICALS LLC (US) 2026-04-02 US disclosed
US-8802808-B2 Casting compounds based on polyurethane BASF AKTIENGESELLSCHAFT (DE) 2014-08-12 US disclosed
US-20100105855-A1 CASTING COMPOUNDS BASED ON POLYURETHANE BASF SE, (DE) 2010-04-29 US disclosed
US-6769220-B2 Structural member FRIESNER CHARLES E (US) 2004-08-03 US disclosed
US-6630050-B1 Contact adhesive for applying paper labels to polyether bottles. HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-10-07 US disclosed
US-20020148181-A1 Structural member FRIESNER CHARLES E (US) 2002-10-17 US disclosed
US-6284841-B1 A DICARBAMATE PREPARED FROM TWO COMPOUNDS WITH AT LEAST TWO ACTIVE HYDROGENS WHICH ARE PARTS OF OH GROUPS AND AT LEAST ONE ETHYLENIC DOUBLE BOND (E.G., CASTOR OIL AND 2-BUTENE-1,4-DIOL) AND A DIISOCYANATE (E.G., TDI) FRIESNER CHARLES E (US) 2001-09-04 US disclosed
US-6169124-B1 USE OF DIESTERS AND/OR MONOESTERS OF ALKYLSUCCINIC AND/OR ALKENYLSUCCINIC ACIDS, BASF AKTIENGESELLSCHAFT (DE) 2001-01-02 US disclosed
US-6107355-A USING ORGANOTIN CATALYST BASF AKTIENGESELLSCHAFT (DE) 2000-08-22 US disclosed
US-6107355-A USING ORGANOTIN CATALYST BASF AKTIENGESELLSCHAFT (DE) 2000-08-22 US disclosed
US-5760099-A Production of rigid or semirigid polyurethane foams and composite elements comprising such polyurethane foams BASF AKTIENGESELLSCHAFT (DE) 1998-06-02 US disclosed
US-5334620-A Production of chlorofluorocarbon-free, urethane-containing moldings having a cellular core and a compacted peripheral zone BASF AKTIENGESELLSCHAFT (DE) 1994-08-02 US disclosed
US-5306798-A Transparent, autoclavable, non-cytotoxic, essentially compact polyurethane embedding compositions, the preparation thereof and the use thereof, especially for articles used in medicine BASF AKTIENGESELLSCHAFT (DE) 1994-04-26 US disclosed
US-5254597-A Production of chlorofluorocarbon-free, urethane-containing moldings having a cellular core and a compacted peripheral zone BASF A.G. (DE) 1993-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092210-A1 BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS MGMT, TST, MPST CYP3A4 1692/4885TSHR 199/4885TDP1 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.